Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
MSC | hg38_v1_chr8_-_71844402_71844429 | -0.36 | 4.6e-02 | Click! |
TFAP4 | hg38_v1_chr16_-_4273014_4273065 | -0.02 | 9.1e-01 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 20.9 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.3 | 19.5 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
1.6 | 15.8 | GO:0035995 | detection of muscle stretch(GO:0035995) |
2.0 | 13.9 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.1 | 13.7 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.1 | 12.8 | GO:0030239 | myofibril assembly(GO:0030239) |
0.1 | 11.3 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.6 | 10.8 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
1.1 | 10.3 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.1 | 8.2 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 44.8 | GO:0030017 | sarcomere(GO:0030017) |
0.8 | 25.9 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.4 | 19.5 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.8 | 16.0 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.2 | 12.2 | GO:0031430 | M band(GO:0031430) |
0.3 | 12.1 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.2 | 10.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.5 | 7.1 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 7.0 | GO:0034707 | chloride channel complex(GO:0034707) |
0.2 | 6.7 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 27.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.9 | 25.9 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.0 | 17.7 | GO:0008017 | microtubule binding(GO:0008017) |
0.5 | 13.5 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 12.6 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.7 | 12.2 | GO:0031433 | telethonin binding(GO:0031433) |
0.2 | 12.2 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.4 | 10.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.9 | 9.5 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 8.7 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 15.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 10.8 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 10.0 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 9.7 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 6.0 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 4.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 3.4 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 3.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 2.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 2.4 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 25.9 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 23.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.3 | 21.9 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.2 | 9.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.4 | 7.8 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 5.0 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 4.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 3.9 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 3.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 3.2 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |